Conferences
19–20 October 2023, San Diego, CA, USA
Microbiome & Probiotic R&D & Business Collaboration Forum: USA
The 2023 Microbiome & Probiotics R&D and Business Collaboration Forum comes at an exciting time for the microbiome industry. The recent FDA approvals for Seres Therapeutics and MaaT Pharma (Phase III Clinical Trial), along with Vedanta Biosciences’ successful fundraising highlight the industry’s potential for a range of therapeutic applications, including the first drugs on the market. Not to forget, Ferring Pharmaceuticals and BiomeBank received FDA approvals last year. With numerous clinical studies underway, momentum has returned to the microbiome industry. Discover the newest advances that are taking place with us, in San Diego, this October.
Topics covered include gut health and disease, as well as the stunning advances being made in understanding the gut–brain axis. Speakers will also report on the developments in Probiotics, Prebiotics, and Postbiotic research as well as personalized nutrition and cardiometabolic disease. For 2023, we have expanded coverage of Women’s health, advances in HMO and infant health, and Cancer. In addition, we will explore the challenges and opportunities in translating research towards commercialization, as well as learn how partnerships and collaborations can secure investment.
